Page last updated: 2024-11-02

pamidronate and Extra-Mammary Paget Disease

pamidronate has been researched along with Extra-Mammary Paget Disease in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Intravenous drip of pamidronate was given at the dose of 30 - 60 mg per day for 2 - 3 weeks with a total dosage of 90 - 270 (168 +/- 84) mg to 5 patients with Paget's disease of bone, 2 males and 3 females, aged 27 - 74 (61 on average) with the course of disease of 4 - 48 years (24 years on average), all of them having multiple bone lesions, 2 being in grade 4 of pain assessment and bedridden and 3 being in grade 3 with impaired mobility."1.32[Prospective study of pamidronate disodium in treatment of Paget's disease of bone]. ( Fu, Y; Jiang, Y; Li, M; Meng, XW; Wang, O; Xia, WB; Xing, XP; Zhang, ZL; Zhou, XY, 2003)
" There was no dose-response relationship between the dose of APD given and the percentage reduction in ALP and HYPRO at 6 months."1.28Bisphosphonate space measurement in Paget's disease of bone treated with APD. ( Evans, AJ; Hosking, DJ; Marshall, DH; Perkins, AC; Stone, MD; Wastie, ML, 1992)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, ZL1
Meng, XW1
Xing, XP1
Wang, O1
Xia, WB1
Li, M1
Jiang, Y1
Fu, Y1
Zhou, XY1
Stone, MD1
Marshall, DH1
Hosking, DJ1
Perkins, AC1
Evans, AJ1
Wastie, ML1

Other Studies

2 other studies available for pamidronate and Extra-Mammary Paget Disease

ArticleYear
[Prospective study of pamidronate disodium in treatment of Paget's disease of bone].
    Zhonghua yi xue za zhi, 2003, Oct-10, Volume: 83, Issue:19

    Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Female; Humans; Male; Middle Age

2003
Bisphosphonate space measurement in Paget's disease of bone treated with APD.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1992, Volume: 7, Issue:3

    Topics: Alkaline Phosphatase; Bone and Bones; Creatinine; Diphosphonates; Humans; Hydroxyproline; Infusions,

1992